partners

    principal partnership

    The EU Malaria Fund is managed by  Investitionsbank Berlin (IBB Group), with public benefit financing provided, among others, through and by the European Investment Bank (EIB). 

    The fund has been initiated by kENUP Foundation. 

    investors & supporters

    The EU Malaria Fund has made arrangements with these distinguished organizations to receive investments and financial support:
    On December 20, 2019 - in the presence of Werner Hoyer, President of the European Investment Bank, Dr. Matthias Kollatz, Senator of Finance of the Federal State of Berlin, and Dr. Jörg Wojahn, Representative of the European Commission to the Federal Republic of Germany - the initial financing agreements establishing the “EU Malaria Fund” have been signed. 
    Through these agreements, the European Commission and the European Investment Bank are investing more than € 110 million into the innovative funding instrument, split between the "First Loss Piece" and the "Senior Tranche". EIB has published these transactions in its public register separately for its Junior and Senior participations. 
    Through the partnership between WHO and EIB - announced at WHO headquarters in Geneva on May 1, 2020 - the agencies collaborate on the EU Malaria Fund with the joint aim to address market failures in developing more effective vaccines, drugs & diagnostics for Malaria. 
    Acting on a decision of its Supervisory Board on December 19, 2019, the Federal State of Berlin - by and through Investitionsbank Berlin, into the Senior Tranche of the Fund. This investment is pursued pari passu with the European Investment Bank EIB.  
    Fondazione Monte dei Paschi di Siena is investing into the Fund's Junior Tranche ("First Loss Piece"), pari passu with the European Commission. 
    The EU Malaria Fund is provided funding for Technical Assistance by the Bill & Melinda Gates Foundation.

    In a press release dated October 9, 2019, the Bill Gates and the European Investment Bank EIB have seconded the project. 
    On May 29, 2020, the Jacques and Gloria Gossweiler Foundation (JGGF) has signed a finance contract with the EU Malaria Fund to govern its investment into the Fund's Senior Tranche.
    Governed by a Grant Agreement dated November 14, 2019, the Foundation for Innovative New Diagnostics (FIND) contributes to the "Donation Tier" of the Fund. 
    Having already supported the set-up of the EU Malaria Fund by providing technical aid, Novartis AG - through and by Sandoz AG - governed by a contract dated November 19, 2019,  is contributing to the Fund's "Donation Tier". 

    policy coordination

    The EU Malaria Fund is coordinating its work with the following distinguished organizations:

    Investitionsbank Berlin

    • Public promotional bank of the Federal State of Berlin
    • Shareholder: State of Berlin, Federal Republic of Germany (100%)
    • Regional business development bank of the State of Berlin
    • Balance sheet of approx. € 17bn
    • Financing commitments of approx. € 926 as of December 31, 2017
    • IFRS-consolidated financial statements
    • Refinancing guarantee by the State of Berlin
    • Headquartered in Berlin with around 620 staff
    • www.ibb.de

    European Investment Bank

    • Financing partner for the EU institutions since 1958
    • Shareholders: 28 EU Member States
    • Largest multilateral lender and borrower in the world
    • Raising funds on the international capital markets
    • Passing on favorable borrowing conditions to clients
    • Around 90% of lending within the EU
    • Approximately 450 projects per annum in over 160 countries
    • Headquartered in Luxembourg with 40 local offices and around 3.000 staff
    • www.eib.org

    kENUP Foundation

    • kENUP is a global partnership in innovation, promoting research based innovation for Europe with public and societal benefit.  It is a not-for-profit organization established as a foundation in the Republic of Malta by Public Deed on November 6, 2014. kENUP’s activities are published in the European Transparency Register.
    • kENUP develops projects to pursue market-leading positions for European innovation businesses. In this capacity, kENUP is supporting the execution of the European Fund for Strategic Investments (EFSI, the so-called “Juncker Plan”),   its successor EFSI 2.0 and the upcoming InvestEU Fund. On these programmes, kENUP works alongide the European Investment Bank (EIB) and with various national and regional public promotional banks.  
    • kENUP formally cooperates with the World Health Organization (WHO), the Organisation for Economic Co-operation and Development (OECD), and with the National Academies of Sciences, Engineering, and Medicine of the United States of America. 
    • www.kenup.eu
    Share by: